Načítá se...
Assessing Pharmacokinetic Marker Correlates of Outcome, with Application to Antibody Prevention Efficacy Trials
The Antibody Mediated Prevention (AMP) efficacy trials are the first studies to evaluate whether passive administration of a broadly neutralizing monoclonal antibody (mAb) can prevent HIV acquisition. The trials randomize 4600 HIV-negative volunteers to receive 10 infusions of the mAb VRC01 or place...
Uloženo v:
| Vydáno v: | Stat Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736712/ https://ncbi.nlm.nih.gov/pubmed/31313349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.8310 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|